You can buy or sell Pfenex and other stocks, options, ETFs, and crypto commission-free!
Pfenex Inc., also called Pfenex, is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. Read More The company was founded on November 19, 2009 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Seeking AlphaMay 13
Pfenex: The First U.S. Forteo Biosim And A Host Of Other Biosims In Pipeline
Using the 351(k) and the 505(b)(2) pathways, Pfenex (NYSEMKT:PFNX) develops biosimilars of major drugs that are going off-patent.
Seeking AlphaMay 11
Pfenex's CEO Eef Schimmelpennink on Q1 2019 Results - Earnings Call Transcript
Pfenex, Inc. (NYSEMKT:PFNX) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Eef Schimmelpennink – Chief Executive Officer Susan Knudson – Chief Financial Officer Conference Call Participants Jason Butler – JMP Securities Andy Hsieh – William Blair Roy Buchanan – JMP Securities Operator Greetings, ladies and gentlemen, and welcome to the Pfenex First Quarter 2019 Results and Business Update Call. A brief question-and-answer session will follow the formal presentation. As...
Expected Aug 8, After Hours